KVUE Stock Price | Kenvue Inc. P/E, Revenue, EPS, & Forecasts

Kenvue Inc. • KVUE

KVUE current price

$23.24+11.36%

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs
News

+2.24%

+8.85%

+29.83%

+16.61%

+11.36%

MAX

-9.25%

Calendar

event

Ex dividend date

14 Aug 2024

event_available

Last Dividend Payment

28 Aug 2024

About Kenvue Inc.

Ticker

KVUE

Trading on

NYSE

ISIN

US49177J1025

Industry

Household & Personal Products

Sector

Consumer Defensive

CEO

Thibaut Mongon

Headquarters

199 Grandview Road, Skillman, NJ, United States, 08558

Employees

22,000

Website

kenvue.com

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

Metrics

BasicAdvanced

Market cap

$44.2B

P/E ratio

40.51

EPS

$0.57

Dividend Yield

3.55%

Beta

Forward P/E ratio

18.69

EBIDTA

$3.63B

Ex dividend date

2024-08-14

Price & volume

Market cap

$44.2B

Average daily volume

12.9M

90-day return

29.83%

30-day return

8.85%

7-day return

2.24%

Dividends

Dividend per share

$0.80

Dividend yield

3.55%

Forward dividend per share

$0.82

Forward dividend yield

$0.04

Payout ratio

65.98%

Valuation

P/E ratio

40.51

Forward P/E

18.69

PEG ratio

6.36

Trailing P/E

40.51

Price to sales

2.86

Price to book

4.34

Earnings

EPS

$0.57

EPS estimate (current quarter)

$0.27

EPS estimate (next quarter)

$0.30

EBITDA

$3.63B

Revenues (TTM)

$15.5B

Revenues per share (TTM)

$8.08

Technicals

Beta

52-week High

$23.47

52-week Low

$17.11

50-day moving average

$20.14

200-day moving average

$20.02

Short ratio

2.84

Short %

2.43%

Management effectiveness

ROE (TTM)

10.55%

ROA (TTM)

6.97%

Profit margin

7.23%

Gross profit margin

$8.34B

Operating margin

17.88%

Growth

Quarterly earnings growth (YoY)

87.00%

Quarterly revenue growth (YoY)

0.30%

Share stats

Outstanding Shares

$1.92B

Float

$1.91B

Insiders %

0.02%

Institutions %

101.31%

Analyst Insights & forecasts

44% Buy

50% Hold

6% Sell

Based on information from 16 analysts.

Average price target

$22.15

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$3.89B

$296M

7.60%

Q1 • 24

$4B

$58M

1.45%

Q2 • 24

2.72%

80.41%

80.92%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$27.3B

$16.7B

61.07%

Q1 • 24

$26.4B

$16.3B

61.51%

Q2 • 24

3.08%

2.38%

0.72%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$287M

$-152M

$-326M

$134M

Q1 • 24

$440M

$-85M

$-490M

$350M

Q2 • 24

53.31%

44.08%

50.31%

161.19%

QoQ growth

QuarterlyAnnual

Sentiment analysis

-1.5

Extreme greed

+1.5

1.04

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Kenvue Inc. share?

Kenvue Inc. shares are currently traded for $23.24 per share.

How many shares does Kenvue Inc. have?

Kenvue Inc. currently has $1.92B shares.

Does Kenvue Inc. pay dividends?

Yes, Kenvue Inc. does pay dividends.

What is Kenvue Inc. 52 week high?

Kenvue Inc. 52 week high is $23.47.

What is Kenvue Inc. 52 week low?

Kenvue Inc. 52 week low is $17.11.

What is the 200-day moving average of Kenvue Inc.?

Kenvue Inc. 200-day moving average is $20.02.

Who is Kenvue Inc. CEO?

The CEO of Kenvue Inc. is Thibaut Mongon.

How many employees Kenvue Inc. has?

Kenvue Inc. has 22,000 employees.

What is the market cap of Kenvue Inc.?

The market cap of Kenvue Inc. is $44.2B.

What is the P/E of Kenvue Inc.?

The current P/E of Kenvue Inc. is 40.51.

What is the EPS of Kenvue Inc.?

The EPS of Kenvue Inc. is $0.57.

What is the PEG Ratio of Kenvue Inc.?

The PEG Ration of Kenvue Inc. is 6.36.

What do analysts say about Kenvue Inc.?

According to the analysts Kenvue Inc. is considered a hold.

Kenvue Inc. news

thumb_up_alt

•Positive

Buy 4 September Dividend Aristocrats And Watch 6

The S&P 500 Dividend Aristocrats list was rebalanced in January 2024, with notable changes including the removal of Walgreens and 3M, and the addition of Fastenal and Kenvue.

Seeking Alpha•10 Sept 2024, 17:25

thumb_up_alt

•Positive

Kenvue Set To Pop Like A Tylenol Gelcap? Golden Cross Looms On Stock Chart

Kenvue Inc. KVUE — the parent company of well-known pharmacy items like Listerine, Mylanta, and Tylenol — is showing a bullish pattern on the charts Tuesday.

Benzinga•10 Sept 2024, 12:48